← Back to headlines
Pulmonx and Beta Bionics Provide 2026 Financial Outlooks
Pulmonx has reiterated its 2026 revenue outlook and gross margin target, while Beta Bionics has outlined its Mint launch timeline and raised its 2026 gross margin outlook. Both companies provided updates on their financial projections.
30 Jul, 06:44 — 30 Jul, 06:44
Sources
Showing 1 of 1 sources
Related Stories
Philippine Lawmakers File Bills Against Electric System Loss Charges
just now
Philippine LTO Extends Permit Validity Amid Technical Issues
just now
Philippines DOTr Aims for Partial Common Station Operations by Q1 2028
just now
EFCC Boss Highlights Contract Fraud as Most Prevalent Corruption in Nigerian Public Sector
just now